Alerts will be sent to your verified email
Verify Email
SPARC
|
Sun Pharma Adv. Res
|
Dishman Carbogen Amc
|
Zenotech Laboratorie
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
675.52 % | 2.05 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
-334.23 % | -0.61 % | 7.83 % |
|
5yr average Equity Multiplier
|
4.89 | 1.56 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.31 | 0.25 | 0.33 |
|
5yr Avg Net Profit Margin
|
-251.32 % | -1.43 % | -17.58 % |
|
Price to Book
|
0.0 | 0.58 | 3.91 |
|
P/E
|
0.0 | 0.0 | 72.89 |
|
5yr Avg Cash Conversion Cycle
|
116.55 Days | 49.26 Days | 36.89 Days |
|
Inventory Days
|
0.0 | 106.35 Days | 145.01 Days |
|
Days Receivable
|
116.55 Days | 73.33 Days | 61.38 Days |
|
Days Payable
|
0.0 | 160.45 Days | 477.06 Days |
|
5yr Average Interest Coverage Ratio
|
-89.89 | 1.02 | -4.03 |
|
5yr Avg ROCE
|
-120.93 % | 1.2 % | 7.95 % |
|
5yr Avg Operating Profit Margin
|
-252.66 % | 15.55 % | 4.66 % |
|
5 yr average Debt to Equity
|
0.92 | 0.26 | 0.12 |
|
5yr CAGR Net Profit
|
13.74 % | n/a | n/a |
|
5yr Average Return on Assets
|
-58.27 % | -0.35 % | 7.07 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.67 % | 59.32 % | 68.84 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.42 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.77 % | -5.69 % | 0.0 |
|
Sun Pharma Adv. Res
|
Dishman Carbogen Amc
|
Zenotech Laboratorie
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|